NASDAQ:ALLO

Allogene Therapeutics Stock Forecast

etoro logo Buy ALLO
*Your capital is at risk
$1.90
+0.0500 (+2.70%)
At Close: Jul 15, 2026
AI Analysis AI Analysis of ALLO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ALLO to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Allogene Therapeutics stock price up 2.70% on Wednesday
(Updated on Jul 15, 2026)

Sell candidate since Jul 10, 2026 Loss -5.00%

The Allogene Therapeutics stock price gained 2.70% on the last trading day (Wednesday, 15th Jul 2026), rising from $1.85 to $1.90. During the last trading day the stock fluctuated 6.37% from a day low at $1.81 to a day high of $1.92. The price has fallen in 6 of the last 10 days and is down by -8.65% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 673 thousand more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $11.45 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.64% during the next 3 months and, with a 90% probability hold a price between $1.43 and $1.86 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ALLO Signals & Forecast

Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Allogene Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.01 and $2.03. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -14.41%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Allogene Therapeutics stock

Allogene Therapeutics finds support from accumulated volume at $1.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.115 between high and low, or 6.37%. For the last week, the stock has had daily average volatility of 5.73%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALLO) For The Upcoming Trading Day Of Thursday 16th

For the upcoming trading day on Thursday, 16th we expect Allogene Therapeutics Inc. to open at $1.88, and during the day (based on 14 day Average True Range), to move between $1.83 and $1.97, which gives a possible trading interval of +/-$0.132 (+/-7.20%) up or down from last closing price. If Allogene Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 7.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.88 (1.05%) than the resistance at $2.00 (5.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Allogene Therapeutics Inc. stock A Buy?

Allogene Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.910 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 16, 2026 - $1.88 ( 1.32%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ALLO Performance

Trading levels for ALLO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.99 4.74%
R2 1.95 2.42%
R1 1.92 1.00%
Price 1.90
S1 1.83 -3.63%
S2 1.80 -5.06%
S3 1.76 -7.37%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.37 24.74%
R2 2.13 12.11%
R1 2.00 5.26%
Price 1.90
S1 1.88 -1.05%
S2 1.85 -2.63%
S3 1.78 -6.32%

FAQ

What is the symbol for Allogene Therapeutics Stock and on which exchange is it traded?
The symbol for Allogene Therapeutics is ALLO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Allogene Therapeutics Stock?
Allogene Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Allogene Therapeutics Stock?
Allogene Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Allogene Therapeutics Stock.

What's the current price of Allogene Therapeutics Stock?
As of the end of day on the Jul 15, 2026, the price of an Allogene Therapeutics (ALLO) share was $1.90.

What is the 52-week high and low for Allogene Therapeutics Stock?
The 52-week high for Allogene Therapeutics Stock is $4.46 and the 52-week low is $0.99.

What is the market capitalization of Allogene Therapeutics Stock?
As of the Jul 15, 2026, the market capitalization of Allogene Therapeutics is 463.352M.

When is the next earnings date for Allogene Therapeutics?
The upcoming earnings date for Allogene Therapeutics is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT ALLOGENE THERAPEUTICS INC.
Allogene Therapeutics
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic ...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
4.04% Jul 13
SRPT
$17.02
3.47% Jun 29
NMRK
$15.02
3.26% Jun 24
JLL
$299.78
9.38% Jun 24
CAG
$13.43
4.94% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE